XML 22 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF MEZZANINE EQUITY AND STOCKHOLDERS’ (DEFICIT) EQUITY - USD ($)
$ in Millions
Total
Redeemable convertible preferred stock
Common Stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Balance at beginning of period, redeemable convertible preferred stock (in shares) at Dec. 31, 2020   412,742,897        
Balance at beginning of period, redeemable convertible preferred stock at Dec. 31, 2020   $ 2,180        
Balance at end of period, redeemable convertible preferred stock (in shares) at Dec. 31, 2021   0        
Balance at end of period, redeemable convertible preferred stock at Dec. 31, 2021   $ 0        
Balance at beginning of period, common stock (in shares) at Dec. 31, 2020     229,031,546      
Balance at beginning of period at Dec. 31, 2020 $ (55)   $ 0 $ 134 $ 1 $ (190)
Increase (decrease) in stockholder's equity            
Net loss (3,687)         (3,687)
Shares issued in connection with stock option exercise, net of repurchases (in shares)     6,832,725      
Shares issued in connection with stock option exercise, net of repurchases 14     14    
Issuance of common stock in connection with Employee Stock Purchase Plan (in shares)     298,031      
Issuance of common stock in connection with Employee Stock Purchase Plan 7     7    
Issuance of common stock in connection with initial public offering, net of issuance costs (in shares)     56,729,194      
Issuance of common stock in connection with initial public offering, net of issuance costs 2,052     2,052    
Issuance of common stock upon settlement of restricted stock units, net of shares withheld (in shares)     32,133,589      
Shares withheld related to net share settlement (in shares)     (11,160,525)      
Shares withheld related to net share settlement (422)     (422)    
Conversion of preferred stock to common stock (in shares)   (412,742,897) 412,742,897      
Conversion of preferred stock to common stock 2,180 $ (2,180)   2,180    
Conversion of convertible notes to common stock (in shares)     137,305,156      
Conversion of convertible notes to common stock 5,218     5,218    
Reclassification of warrant liability to stockholders' equity 380     380    
Change in other comprehensive loss 0          
Vesting of replacement awards issued in connection with acquisition 1     1    
Share-based compensation 1,605     1,605    
Balance at end of period, common stock (in shares) at Dec. 31, 2021 [1]     863,912,613      
Ending balance at Dec. 31, 2021 7,293   $ 0 [1] 11,169 1 (3,877)
Balance at end of period, redeemable convertible preferred stock (in shares) at Dec. 31, 2022   0        
Balance at end of period, redeemable convertible preferred stock at Dec. 31, 2022   $ 0        
Increase (decrease) in stockholder's equity            
Net loss (1,028)         (1,028)
Shares issued in connection with stock option exercise, net of repurchases (in shares) [1]     2,318,267      
Shares issued in connection with stock option exercise, net of repurchases 6     6    
Issuance of common stock in connection with Employee Stock Purchase Plan (in shares) [1]     1,907,241      
Issuance of common stock in connection with Employee Stock Purchase Plan 16     16    
Issuance of common stock upon settlement of restricted stock units, net of shares withheld (in shares) [1]     24,613,450      
Issuance of common stock upon settlement of restricted stock units, net of shares withheld (12)     (12)    
Change in other comprehensive loss (1)       (1)  
Share-based compensation 682     682    
Balance at end of period, common stock (in shares) at Dec. 31, 2022 [1]     892,751,571      
Ending balance at Dec. 31, 2022 6,956   $ 0 [1] 11,861 0 (4,905)
Increase (decrease) in stockholder's equity            
Net loss (541)         (541)
Shares issued in connection with stock option exercise, net of repurchases (in shares) [1]     2,449,169      
Shares issued in connection with stock option exercise, net of repurchases 5     5    
Issuance of common stock in connection with Employee Stock Purchase Plan (in shares) [1]     1,968,081      
Issuance of common stock in connection with Employee Stock Purchase Plan 14     14    
Issuance of common stock upon settlement of restricted stock units, net of shares withheld (in shares) [1]     30,267,312      
Issuance of common stock upon settlement of restricted stock units, net of shares withheld (12)     (12)    
Repurchase and retirement of Class A common stock (in shares) [1]     (55,273,469)      
Repurchase and retirement of Class A common stock (611)     (611)    
Change in other comprehensive loss (3)       (3)  
Share-based compensation 888     888    
Balance at end of period, common stock (in shares) at Dec. 31, 2023 [1]     872,162,664      
Ending balance at Dec. 31, 2023 $ 6,696   $ 0 [1] $ 12,145 $ (3) $ (5,446)
[1] The share amounts listed above combine common stock, Class A common stock and Class B common stock. In connection with the completion of our initial public offering, all previously outstanding shares of common stock were reclassified into Class A common stock and Class B common stock. See Note 1 - Description of Business and Summary of Significant Accounting Policies, for further information.